207 related articles for article (PubMed ID: 6402767)
21. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay.
Wagener C; Clark BR; Rickard KJ; Shively JE
J Immunol; 1983 May; 130(5):2302-7. PubMed ID: 6187848
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
[TBL] [Abstract][Full Text] [Related]
23. CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies.
Verstijnen CP; Arends JW; Moerkerk PT; Warnaar S; Hilgers J; Bosman FT
Anticancer Res; 1986; 6(1):97-104. PubMed ID: 2420267
[TBL] [Abstract][Full Text] [Related]
24. [Carcinoembryonic antigen gene family and its clinical application].
Hinoda Y; Imai K
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1274-80. PubMed ID: 2195999
[TBL] [Abstract][Full Text] [Related]
25. Production and characterization of monoclonal antibodies against human IgG in Balb/c mouse.
Majidi J; Baradaran B; Hassan ZM; Mostafaie A
Hum Antibodies; 2005; 14(1-2):1-5. PubMed ID: 16424594
[TBL] [Abstract][Full Text] [Related]
26. Production and characterization of monoclonal antibodies against tissue-type plasminogen activator.
Ding H; Wang JY; Song HY
Chin J Biotechnol; 1990; 6(3):223-7. PubMed ID: 2129498
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of carcinoembryonic antigens and non cross-reacting antigens in the human thymus. Analysis on frozen sections and cultured epithelial cells using monoclonal antibodies.
Aubry J; Cohen-Kaminsky S; Berrih-Aknin S
Thymus; 1990 Mar; 15(2):107-23. PubMed ID: 2185585
[TBL] [Abstract][Full Text] [Related]
28. Epitope mapping of the carcinoembryonic antigen by monoclonal antibodies and establishment of a new improved radioimmunoassay system.
Kuroki M; Arakawa F; Higuchi H; Matsunaga A; Okamoto N; Takakura K; Matsuoka Y
Jpn J Cancer Res; 1987 Apr; 78(4):386-96. PubMed ID: 2438262
[TBL] [Abstract][Full Text] [Related]
29. Development of hybridoma cells producing monoclonal antibody against human epsilon (epsilon) chain.
Majidi J; Hassan ZM
Hum Antibodies; 2003; 12(3):93-8. PubMed ID: 14646037
[TBL] [Abstract][Full Text] [Related]
30. [Production of monoclonal antibodies against human cytomegalovirus].
Mazeron MC; Berbar T; Guillemin MC; Colimon R; Roseto A; Perol Y
C R Seances Acad Sci III; 1983; 297(6):305-8. PubMed ID: 6318932
[TBL] [Abstract][Full Text] [Related]
31. Cross-linking of the carcinoembryonic antigen-like glycoproteins CD66 and CD67 induces neutrophil aggregation.
Kuijpers TW; van der Schoot CE; Hoogerwerf M; Roos D
J Immunol; 1993 Nov; 151(9):4934-40. PubMed ID: 8104998
[TBL] [Abstract][Full Text] [Related]
32. Nonspecific cross-reacting antigen-50/90 (NCA-50/90) as a new tumor marker.
Kuroki M; Matsushita H; Matsumoto H; Hirose Y; Senba T; Yamamoto T
Anticancer Res; 1999; 19(6C):5599-606. PubMed ID: 10697625
[TBL] [Abstract][Full Text] [Related]
33. [Generation and characterization of monoclonal antibody GCF-5 to human giant cell tumor of bone].
Zhou L
Zhonghua Wai Ke Za Zhi; 1993 Feb; 31(2):79-81. PubMed ID: 8223010
[TBL] [Abstract][Full Text] [Related]
34. Immunochemical identification of an alpha 1-acid glycoprotein-antigenic determinant on carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA).
Ochi Y; Ura Y; Hamazu M; Fujiyama Y; Kajita Y; Ishida M; Miyazaki T; Tamura K
Clin Chim Acta; 1984 Mar; 138(1):9-19. PubMed ID: 6201306
[TBL] [Abstract][Full Text] [Related]
35. ["Non-specific cross reacting antigen (NCA)", a tracer of human granulocytes and monocytes].
Burtin P
C R Seances Soc Biol Fil; 1979; 173(2):261-9. PubMed ID: 92357
[TBL] [Abstract][Full Text] [Related]
36. Two CEA cross-reacting antigens: differences in absorbing the same anti-CEA serum.
Ferrara RM; Biancardi C; Cavalca V; Botta M; Bailo M; Bartorelli A
Cancer Detect Prev; 1987; 10(1-2):101-8. PubMed ID: 3568003
[TBL] [Abstract][Full Text] [Related]
37. Coproduction of carcinoembryonic antigen and nonspecific cross-reacting antigen by a continuous cell line from a human pancreatic tumor.
Kuroki M; Ichiki S; Kuroki M; Matsuoka Y
J Natl Cancer Inst; 1982 Aug; 69(2):401-8. PubMed ID: 6810002
[TBL] [Abstract][Full Text] [Related]
38. Generation, immunologic characterization and antitumor effects of human monoclonal antibodies for carcinoembryonic antigen.
Imakiire T; Kuroki M; Shibaguchi H; Abe H; Yamauchi Y; Ueno A; Hirose Y; Yamada H; Yamashita Y; Shirakusa T; Ishida I; Kuroki M
Int J Cancer; 2004 Feb; 108(4):564-70. PubMed ID: 14696121
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
Audette M; Buchegger F; Schreyer M; Mach JP
Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
[TBL] [Abstract][Full Text] [Related]
40. The production of hybridoma cell line secreting monoclonal antibodies against Xanthomonas campestris pv. oryzae and its application in the classification of strains.
Huang B; Zhu H; Hu G; Li Q; Gao J; Liu S
Chin J Biotechnol; 1992; 8(2):139-44. PubMed ID: 1284289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
